Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H18ClN.ClH |
Molecular Weight | 296.235 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C[C@@H](CC1=CC=CC=C1)NCC2=CC=CC=C2Cl
InChI
InChIKey=ASTCUURTJCZRSC-ZOWNYOTGSA-N
InChI=1S/C16H18ClN.ClH/c1-13(11-14-7-3-2-4-8-14)18-12-15-9-5-6-10-16(15)17;/h2-10,13,18H,11-12H2,1H3;1H/t13-;/m0./s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/18500382Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/9987865 | https://www.ncbi.nlm.nih.gov/pubmed/9050090
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18500382
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/9987865 | https://www.ncbi.nlm.nih.gov/pubmed/9050090
Clobenzorex is a central stimulant and sympathomimetic used as an anti-obesity drug; an n-substituted amphetamine, which is metabolized to amphethamine. Its actions are like those of dexamphetamine and has been used as a drug of abuse.
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Clobenzorex: evidence for amphetamine-like behavioral actions. | 1997 Feb |
|
Amphetamine, clobenzorex, and 4-hydroxyclobenzorex levels following multidose administration of clobenzorex. | 2001 Apr |
|
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. | 2002 Apr |
|
Precursor medications as a source of methamphetamine and/or amphetamine positive drug testing results. | 2002 May |
|
Amphetamine-like stimulant cessation in an abusing patient treated with bupropion. | 2004 Jan |
|
Role of substance P on histamine H(3) antagonist-induced scratching behavior in mice. | 2006 Apr |
|
Benfluorex and unexplained valvular heart disease: a case-control study. | 2010 Apr 12 |
|
Drugs and dilated cardiomyopathies: A case/noncase study in the French PharmacoVigilance Database. | 2010 Mar |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
BC6X5MB664
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
m3627
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB01345MIG
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
5843-53-8
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
DTXSID0046145
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
C000490
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
DBSALT002797
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
71314913
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
236205
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | RxNorm | ||
|
100000087932
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY | |||
|
227-434-5
Created by
admin on Fri Dec 15 17:35:27 GMT 2023 , Edited by admin on Fri Dec 15 17:35:27 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD